Stockhead TV
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Island Pharmaceuticals.
RELATED STOCKHEAD STORIES
Stockhead TV
Long Shortz with Island Pharmaceuticals: Phase 2b trial into dengue fever kicks off
Health & Biotech
Health Check: Which stock just dumped 19% on earnings downgrade?
Health & Biotech
Island Pharmaceuticals starts phase 2b dengue trial
Stockhead TV
Long Shortz with Island Pharmaceuticals: Trial success with dengue fever drug
News
ASX Lunch Wrap: ASX a sea of green after ceasefire; Island Pharma up 30pc on trial results
Health & Biotech
Health Check: ASX sleep company emerges from slumber with a revenue and earnings upgrade
Health & Biotech
Health Check: Chinese consumer market is a thing of beauty, says EZZ Life Sciences
Health & Biotech
Health Check: Mayne Pharma and Acrux are on a drug expansion drive, generically speaking
Health & Biotech
Health Check: Painchek strives to Make American Aged Folk Comfortable Again
Health & Biotech
Biocurious: Island Pharmaceuticals’ two-pronged plan to put the mozz on dengue fever
Health & Biotech
Health Check: Which biotech boards are at risk of a ‘second strike’?
Health & Biotech
‘Breakthrough’ quarter for Island Pharmaceuticals
Health & Biotech
Health Check: It’s all in the vibe as Invion and Wellness Life shrink to share greatness
Health & Biotech
Health Check: Thirsty Chimeric goes to the well for funding top-up
News
ASX Small Caps Weekly Wrap: A long run for a short slide as the ASX ends flat
Health & Biotech
Health Check: Lion City’s Orthocell approval provides a Singapore Sling-board to Asian markets
News
